Trials / Sponsors / ImmuPharma
ImmuPharma
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With System Lupus Erythematosus, Systemic | Phase 3 | 2018-02-27 |
| Completed | A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Saf Lupus Erythematosus, Systemic | Phase 3 | 2015-03-01 |